CoChat

Inhibition of CD4(+)25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Abstract

Regulatory T cells (T(REGs)) control the key aspects of tolerance and play a role in the lack of antitumor immune responses. Cyclophosphamide (CY) is a chemotherapeutic agent with a dose-dependent, bimodal effect on the immune system. Although a previous study demonstrated that CY reduces the number of T(REGs), the mechanism involved in this process has yet to be defined. In this report, it is established that low-dose CY not only decreases cell number but leads to decreased functionality of T(REGs). CY treatment enhances apoptosis and decreases homeostatic proliferation of these cells. Expression of GITR and FoxP3, which are involved in the suppressive activity of T(REGs), is down-regulated after CY administration, though the level of expression varies depending on the time studied. This is the first report demonstrating that CY, in addition to decreasing cell number, inhibits the suppressive capability of T(REGs). The relevance of the loss of suppressor functionality and the changes in gene expression are further discussed.

Overview

Integrity signals

Registry

Crossref · 10.1182/blood-2004-06-2410

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 37 references

Cited by

See all 982

Metadata

Authors
Lutsiak, M. E. C., Semnani, R. T., De Pascalis, R., Kashmiri, S. V. S., Schlom, J., & Sabzevari, H.
Affiliations
  • National Institutes of Health (US)
  • From the Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health; and Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.
Venue
Blood
Published
2005-04-01
Volume
105
Issue
7
Pages
2862-2868
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W2137049683
Cited by
903
References
37
Citations by year
2026: 12 · 2025: 19 · 2024: 20 · 2023: 23 · 2022: 27 · 2021: 36 · 2020: 36 · 2019: 38 · 2018: 29 · 2017: 37 · 2016: 50 · 2015: 51 · 2014: 52 · 2013: 69 · 2012: 58
FWCI
18.92
Type
journal article
Language
en
Open access
closed
Locations
  • Blood (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotoxicology and immune responses
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Keywords
regulatory T cells, cyclophosphamide, low-dose immunosuppression, Treg suppressive function, GITR, Foxp3, apoptosis, homeostatic proliferation, immune tolerance, antitumor immunity
MeSH terms
Animals, Antigens, Surface, B-Lymphocytes, Cell Differentiation, Cyclophosphamide, DNA-Binding Proteins, Female, Immunosuppressive Agents, Mice, Inbred C57BL, Receptors, Interleukin-2, CD4-Positive T-Lymphocytes, Gene Expression, Apoptosis, Receptors, Nerve Growth Factor, Receptors, Tumor Necrosis Factor, Mice, Forkhead Transcription Factors, Glucocorticoid-Induced TNFR-Related Protein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Inhibition of CD4(+)25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide. https://app.cochat.ai/papers/10.1182/blood-2004-06-2410
The paper
Lutsiak, M. E. C., Semnani, R. T., De Pascalis, R., Kashmiri, S. V. S., Schlom, J., & Sabzevari, H. (2005). Inhibition of CD4(+)25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide. Blood. https://doi.org/10.1182/blood-2004-06-2410

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.